CSC Patient Safety & Complication Management Flashcards
6 cards from real CSC practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 6 CSC Patient Safety & Complication Management flashcards as text
Which complication is the most common serious adverse event associated with moderate sedation?
Answer: Respiratory depression
Respiratory depression is the most common life-threatening complication of moderate sedation due to CNS depression caused by sedative and opioid agents.
What is the reversal agent for benzodiazepine-induced respiratory depression?
Answer: Flumazenil (Romazicon)
Flumazenil competitively antagonizes benzodiazepine receptors in the CNS, reversing sedation and respiratory depression caused by benzodiazepines.
When administering naloxone to reverse opioid-induced respiratory depression during sedation, what is a key risk the nurse must anticipate?
Answer: Re-narcotization after naloxone wears off
Naloxone has a shorter half-life than most opioids, so re-narcotization can occur after the reversal agent wears off, requiring continued monitoring.
A patient develops laryngospasm during moderate sedation. What is the PRIORITY nursing intervention?
Answer: Apply positive pressure oxygen with a bag-valve mask and call for help
Initial management of laryngospasm includes applying firm positive pressure oxygen via bag-valve mask while simultaneously calling for emergency assistance.
Which patient history finding represents the GREATEST risk factor for aspiration during moderate sedation?
Answer: Gastroesophageal reflux disease (GERD)
GERD predisposes patients to regurgitation of gastric contents, significantly increasing the risk of aspiration during sedation when protective airway reflexes are diminished.
What is the recommended minimum observation period in the recovery area after the last dose of moderate sedation medication before patient discharge?
Answer: 1 hour
Most institutional and professional guidelines recommend at least 1 hour of monitored recovery after the last dose of sedation before discharge evaluation.